Human tissue-engineered blood vessels for adult arterial revascularization

By N. L’Heureux, N. Dusserre, G. Konig, B. Victor, P. Keire, T. Wight, N. Chronos, A. Kyles, C. Gregory, G. Hoyt and 2 more. Nature Medicine, 2007

1,067 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Tissue Engineering by Self-Assembly of Cells Printed into Topologically Defined Structures (2007, positive): “Recent efforts have concentrated on scaffoldless tissue engineering 18–21 and produced promising results even if they are limited to speciﬁc applications and are not scalable.”
Collagen-Based Biomaterials for Tissue Engineering Applications (2010, background): “This tissue-engineered blood vessel has been successfully grafted on patients [149,150].”
Electrospun Scaffolds for Tissue Engineering of Vascular Grafts (2013, neutral): “In-depth reviews about the electrospinning process can be found elsewhere [15–23].”
Scaffold-Free Vascular Tissue Engineering Using Bioprinting (2009, background): “Therefore it is not surprising that the first clinical applications of tissueengineered vascular grafts have either targeted low-pressure applications [4] or relied on an entirely scaffold-free method termed sheet-based tissue-engineering [15-18] (currently under study also for myocardial reconstruc”
The Tissue-Engineered Vascular Graft—Past, Present, and Future (2015, methodology): “The major limitation of using TESA is the extended in vitro culture periods required, with multiple months needed for sheet-based TEVGs to achieve suitable mechanical integrity for vascular applications.(63,168) This drawback may be circumvented in the future by production in anticipation of the ind”